Umbilical Cord-Derived Mesenchymal Stem Cells are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications

Mesenchymal stem cells (MSCs) have become a promising tool in cellular therapy for restoring immune system haemostasis; however, the success of clinical trials has been impaired by the lack of standardized manufacturing processes. This study aims to determine the suitability of source tissues and cu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Lenka Tesarova, Klara Jaresova, Pavel Simara, Irena Koutna
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2020-07-01
coleção:International Journal of Molecular Sciences
Assuntos:
mesenchymal stem cells
umbilical cord
advanced therapy medicinal product
immunosuppression
Acesso em linha:https://www.mdpi.com/1422-0067/21/15/5366
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados